These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 580135)

  • 1. The relationship between circulating free and bound insulin, insulin antibodies, insulin dosage and diabetic control in insulin treated diabetics.
    Asplin CM; Hartog M; Goldie DJ
    Acta Endocrinol (Copenh); 1978 Feb; 87(2):330-8. PubMed ID: 580135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum IRI in insulin-treated diabetics during a 24-hour period.
    Rasmussen SM; Heding LG; Parbst E; Volund A
    Diabetologia; 1975 Apr; 11(2):151-8. PubMed ID: 1149948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change of insulin dosage, circulating free and bound insulin and insulin antibodies on transferring diabetics from conventional to highly purified porcine insulin.
    Asplin CM; Hartog M; Goldie DJ
    Diabetologia; 1978 Feb; 14(2):99-105. PubMed ID: 631462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison between diabetics receiving a high or low daily insulin dosage.
    Asplin CM; Hartog M; Goldie DJ; Alberti KG; Smythe P; Binder C; Fabero OK
    Horm Metab Res; 1978 Sep; 10(5):365-9. PubMed ID: 568594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple method for the determination of serum free insulin levels in insulin-treated patients.
    Nakagawa S; Nakayama H; Sasaki T; Yoshino K; Yu YY
    Diabetes; 1973 Aug; 22(8):590-600. PubMed ID: 4579520
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum free insulin concentrations during the treatment of diabetic coma and precoma with low dose intramuscular insulin.
    Asplin CM; Hartog M
    Diabetologia; 1977 Sep; 13(5):475-80. PubMed ID: 908471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dynamics of free, total and antibody-bound insulin in diabetes mellitus patients in the process of treatment with swine insulin].
    Pliats OM; Alekseev IuP
    Probl Endokrinol (Mosk); 1977; 23(2):3-6. PubMed ID: 561956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical observation on brittle diabetes.
    Lev-Ran A
    Arch Intern Med; 1978 Mar; 138(3):372-6. PubMed ID: 629631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of morning hyperglycaemia: determinants of fasting blood glucose concentrations in insulin-treated diabetics.
    Francis AJ; Home PD; Walford S; Alberti KG; Mann N; Reeves WG
    Diabet Med; 1985 Mar; 2(2):89-94. PubMed ID: 2952408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual pancreatic function in insulin dependent diabetics.
    Glatthaar C; Beaven DW; Donald RA; Smith JR; Espiner EA
    Aust N Z J Med; 1982 Feb; 12(1):43-7. PubMed ID: 7044357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Free, total and antibody-bound insulin content in newly detected diabetes mellitus patients].
    Mosin VI; Morozova NN; Salanda BS
    Probl Endokrinol (Mosk); 1980; 26(5):6-11. PubMed ID: 7001439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating antibodies in diabetics treated with conventional and purified insulins.
    Klaff LJ; Vinik AI; Berelowitz M; Jackson WP
    S Afr Med J; 1978 Jul; 54(4):149-53. PubMed ID: 694712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The bioavailability of circulating antibody-bound insulin following insulin withdrawal in Type 1 (insulin-dependent) diabetes.
    Vaughan NJ; Matthews JA; Kurtz AB; Nabarro JD
    Diabetologia; 1983 May; 24(5):355-8. PubMed ID: 6347783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistant diabetes mellitus.
    Zhu XX; Wang ZG; Qiu CL; Zhong XL
    Chin Med J (Engl); 1980 Nov; 93(11):737-44. PubMed ID: 6775883
    [No Abstract]   [Full Text] [Related]  

  • 15. The production and characteristics of anti-insulin, anti-A-component and anti-proinsulin antibodies in patients treated with monocomponent or conventional insulin.
    Kawazu S; Kanazawa Y; Miki E; Hayashi M; Sando H; Kajinuma H; Iwamoto Y; Akanuma Y; Kosaka K
    Acta Diabetol Lat; 1979; 16(4):339-51. PubMed ID: 399151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of insulin absorption and sensitivity in determining a diabetic's daily insulin dosage.
    Asplin CM; Hartog M; Goldie DJ; Smythe P; Alberti KG
    Acta Endocrinol (Copenh); 1980 Feb; 93(2):190-5. PubMed ID: 6990672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interrelationships of blood sugar and ketones in insulin-treated diabetics.
    Watkins PJ; Fitzgerald MG; Malins JM
    Br Med J; 1969 Dec; 4(5684):648-51. PubMed ID: 4982785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical-biochemical studies of the insulin-like activity of the serum of diabetics in fasting and after oral glucose].
    Dobrzański T
    Klin Wochenschr; 1966 Feb; 44(4):194-202. PubMed ID: 5982881
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of insulin therapy on insulin resistance in type II diabetic subjects. Evidence for heterogeneity.
    Ginsberg H; Rayfield EJ
    Diabetes; 1981 Sep; 30(9):739-45. PubMed ID: 7021272
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum insulin, insulin antibodies and insulin requirement in the first period of insulin treatment in non-insulin resistant diabetics.
    Lev-Ran A; Ratt L; Gersht N
    Acta Diabetol Lat; 1975; 12(1):66-71. PubMed ID: 1229807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.